Copyright Reports & Markets. All rights reserved.

Global Ceftazidime Avibactam Sodium for Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Ceftazidime Avibactam Sodium for Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Original Drug
    • 1.3.3 Generic Drug
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Ceftazidime Avibactam Sodium for Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Ceftazidime Avibactam Sodium for Injection Market Size & Forecast
    • 1.5.1 Global Ceftazidime Avibactam Sodium for Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Ceftazidime Avibactam Sodium for Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Ceftazidime Avibactam Sodium for Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Nanjing Entai Pharmaceutical Technology Co., Ltd.
    • 2.1.1 Nanjing Entai Pharmaceutical Technology Co., Ltd. Details
    • 2.1.2 Nanjing Entai Pharmaceutical Technology Co., Ltd. Major Business
    • 2.1.3 Nanjing Entai Pharmaceutical Technology Co., Ltd. Ceftazidime Avibactam Sodium for Injection Product and Services
    • 2.1.4 Nanjing Entai Pharmaceutical Technology Co., Ltd. Ceftazidime Avibactam Sodium for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Nanjing Entai Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
  • 2.2 Pfizer
    • 2.2.1 Pfizer Details
    • 2.2.2 Pfizer Major Business
    • 2.2.3 Pfizer Ceftazidime Avibactam Sodium for Injection Product and Services
    • 2.2.4 Pfizer Ceftazidime Avibactam Sodium for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Pfizer Recent Developments/Updates
  • 2.3 Qilu Pharmaceutical
    • 2.3.1 Qilu Pharmaceutical Details
    • 2.3.2 Qilu Pharmaceutical Major Business
    • 2.3.3 Qilu Pharmaceutical Ceftazidime Avibactam Sodium for Injection Product and Services
    • 2.3.4 Qilu Pharmaceutical Ceftazidime Avibactam Sodium for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Qilu Pharmaceutical Recent Developments/Updates
  • 2.4 Shandong Bestcomm Pharmaceutical Co., Ltd.
    • 2.4.1 Shandong Bestcomm Pharmaceutical Co., Ltd. Details
    • 2.4.2 Shandong Bestcomm Pharmaceutical Co., Ltd. Major Business
    • 2.4.3 Shandong Bestcomm Pharmaceutical Co., Ltd. Ceftazidime Avibactam Sodium for Injection Product and Services
    • 2.4.4 Shandong Bestcomm Pharmaceutical Co., Ltd. Ceftazidime Avibactam Sodium for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Shandong Bestcomm Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.5 Sichuan Kelun Pharmaceutical Co., Ltd.
    • 2.5.1 Sichuan Kelun Pharmaceutical Co., Ltd. Details
    • 2.5.2 Sichuan Kelun Pharmaceutical Co., Ltd. Major Business
    • 2.5.3 Sichuan Kelun Pharmaceutical Co., Ltd. Ceftazidime Avibactam Sodium for Injection Product and Services
    • 2.5.4 Sichuan Kelun Pharmaceutical Co., Ltd. Ceftazidime Avibactam Sodium for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.6 China Resources Sanjiu Medical & Pharmaceutical
    • 2.6.1 China Resources Sanjiu Medical & Pharmaceutical Details
    • 2.6.2 China Resources Sanjiu Medical & Pharmaceutical Major Business
    • 2.6.3 China Resources Sanjiu Medical & Pharmaceutical Ceftazidime Avibactam Sodium for Injection Product and Services
    • 2.6.4 China Resources Sanjiu Medical & Pharmaceutical Ceftazidime Avibactam Sodium for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 China Resources Sanjiu Medical & Pharmaceutical Recent Developments/Updates
  • 2.7 Intellicure Lifesciences
    • 2.7.1 Intellicure Lifesciences Details
    • 2.7.2 Intellicure Lifesciences Major Business
    • 2.7.3 Intellicure Lifesciences Ceftazidime Avibactam Sodium for Injection Product and Services
    • 2.7.4 Intellicure Lifesciences Ceftazidime Avibactam Sodium for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Intellicure Lifesciences Recent Developments/Updates

3 Competitive Environment: Ceftazidime Avibactam Sodium for Injection by Manufacturer

  • 3.1 Global Ceftazidime Avibactam Sodium for Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Ceftazidime Avibactam Sodium for Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Ceftazidime Avibactam Sodium for Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Ceftazidime Avibactam Sodium for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Ceftazidime Avibactam Sodium for Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Ceftazidime Avibactam Sodium for Injection Manufacturer Market Share in 2025
  • 3.5 Ceftazidime Avibactam Sodium for Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Ceftazidime Avibactam Sodium for Injection Market: Region Footprint
    • 3.5.2 Ceftazidime Avibactam Sodium for Injection Market: Company Product Type Footprint
    • 3.5.3 Ceftazidime Avibactam Sodium for Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Ceftazidime Avibactam Sodium for Injection Market Size by Region
    • 4.1.1 Global Ceftazidime Avibactam Sodium for Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Ceftazidime Avibactam Sodium for Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Ceftazidime Avibactam Sodium for Injection Average Price by Region (2021-2032)
  • 4.2 North America Ceftazidime Avibactam Sodium for Injection Consumption Value (2021-2032)
  • 4.3 Europe Ceftazidime Avibactam Sodium for Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Ceftazidime Avibactam Sodium for Injection Consumption Value (2021-2032)
  • 4.5 South America Ceftazidime Avibactam Sodium for Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Ceftazidime Avibactam Sodium for Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Ceftazidime Avibactam Sodium for Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Ceftazidime Avibactam Sodium for Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Ceftazidime Avibactam Sodium for Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Ceftazidime Avibactam Sodium for Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Ceftazidime Avibactam Sodium for Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Ceftazidime Avibactam Sodium for Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Ceftazidime Avibactam Sodium for Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Ceftazidime Avibactam Sodium for Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Ceftazidime Avibactam Sodium for Injection Market Size by Country
    • 7.3.1 North America Ceftazidime Avibactam Sodium for Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Ceftazidime Avibactam Sodium for Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Ceftazidime Avibactam Sodium for Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Ceftazidime Avibactam Sodium for Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Ceftazidime Avibactam Sodium for Injection Market Size by Country
    • 8.3.1 Europe Ceftazidime Avibactam Sodium for Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Ceftazidime Avibactam Sodium for Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Ceftazidime Avibactam Sodium for Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Ceftazidime Avibactam Sodium for Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Ceftazidime Avibactam Sodium for Injection Market Size by Region
    • 9.3.1 Asia-Pacific Ceftazidime Avibactam Sodium for Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Ceftazidime Avibactam Sodium for Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Ceftazidime Avibactam Sodium for Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Ceftazidime Avibactam Sodium for Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Ceftazidime Avibactam Sodium for Injection Market Size by Country
    • 10.3.1 South America Ceftazidime Avibactam Sodium for Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Ceftazidime Avibactam Sodium for Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Ceftazidime Avibactam Sodium for Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Ceftazidime Avibactam Sodium for Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Ceftazidime Avibactam Sodium for Injection Market Size by Country
    • 11.3.1 Middle East & Africa Ceftazidime Avibactam Sodium for Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Ceftazidime Avibactam Sodium for Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Ceftazidime Avibactam Sodium for Injection Market Drivers
  • 12.2 Ceftazidime Avibactam Sodium for Injection Market Restraints
  • 12.3 Ceftazidime Avibactam Sodium for Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Ceftazidime Avibactam Sodium for Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Ceftazidime Avibactam Sodium for Injection
  • 13.3 Ceftazidime Avibactam Sodium for Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Ceftazidime Avibactam Sodium for Injection Typical Distributors
  • 14.3 Ceftazidime Avibactam Sodium for Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Ceftazidime Avibactam Sodium for Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Ceftazidime Avibactam Sodium for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Ceftazidime Avibactam Sodium for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Bottles), and average selling prices (US$/Bottle), 2021-2032
    Global Ceftazidime Avibactam Sodium for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Bottles), and average selling prices (US$/Bottle), 2021-2032
    Global Ceftazidime Avibactam Sodium for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Bottles), and average selling prices (US$/Bottle), 2021-2032
    Global Ceftazidime Avibactam Sodium for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Bottles), and ASP (US$/Bottle), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Ceftazidime Avibactam Sodium for Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Ceftazidime Avibactam Sodium for Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nanjing Entai Pharmaceutical Technology Co., Ltd., Pfizer, Qilu Pharmaceutical, Shandong Bestcomm Pharmaceutical Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., China Resources Sanjiu Medical & Pharmaceutical, Intellicure Lifesciences, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Ceftazidime Avibactam Sodium for Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Original Drug
    Generic Drug
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    Nanjing Entai Pharmaceutical Technology Co., Ltd.
    Pfizer
    Qilu Pharmaceutical
    Shandong Bestcomm Pharmaceutical Co., Ltd.
    Sichuan Kelun Pharmaceutical Co., Ltd.
    China Resources Sanjiu Medical & Pharmaceutical
    Intellicure Lifesciences
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Ceftazidime Avibactam Sodium for Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Ceftazidime Avibactam Sodium for Injection, with price, sales quantity, revenue, and global market share of Ceftazidime Avibactam Sodium for Injection from 2021 to 2026.
    Chapter 3, the Ceftazidime Avibactam Sodium for Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Ceftazidime Avibactam Sodium for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Ceftazidime Avibactam Sodium for Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Ceftazidime Avibactam Sodium for Injection.
    Chapter 14 and 15, to describe Ceftazidime Avibactam Sodium for Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now